Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867008288480034816 |
|---|---|
| author | Jing Yang James S Lewis Jinghuan Zi Thomas Andl Ethan Lee Claudia D Andl Qi Liu Robert D Beauchamp Anna L Means |
| author_facet | Jing Yang James S Lewis Jinghuan Zi Thomas Andl Ethan Lee Claudia D Andl Qi Liu Robert D Beauchamp Anna L Means Jing Yang James S Lewis Jinghuan Zi Thomas Andl Ethan Lee Claudia D Andl Qi Liu Robert D Beauchamp Anna L Means |
| collection | Wiley Open Access |
| contents | Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma Jing Yang James S Lewis Jinghuan Zi Thomas Andl Ethan Lee Claudia D Andl Qi Liu Robert D Beauchamp Anna L Means The Journal of Pathology AbstractSMAD4 is a tumor suppressor mutated or silenced in multiple cancers, including oral cavity squamous cell carcinoma (OSCC). Human clinical samples and cell lines, mouse models and organoid culture were used to investigate the role that SMAD4 plays in progression from benign disease to invasive OSCC. Human OSCC lost detectable SMAD4 protein within tumor epithelium in 24% of cases, and this loss correlated with worse progression‐free survival independent of other major clinical and pathological features. A mouse model engineered for KrasG12D expression in the adult oral epithelium induced benign papillomas, however the combination of KrasG12D with loss of epithelial Smad4 expression resulted in rapid development of invasive carcinoma with features of human OSCC. Examination of regulatory pathways in 3D organoid cultures of SMAD4+ and SMAD4− mouse tumors with Kras mutation found that either loss of SMAD4 or inhibition of TGFβ signaling upregulated the WNT pathway and altered the extracellular matrix. The gene signature of the mouse tumor organoids lacking SMAD4 was highly similar to the gene signature of human head and neck squamous cell carcinoma. In summary, this work has uncovered novel mechanisms by which SMAD4 acts as a tumor suppressor in OSCC. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6318 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| doi_str_mv | 10.1002/path.6318 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_path_6318 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma Jing Yang James S Lewis Jinghuan Zi Thomas Andl Ethan Lee Claudia D Andl Qi Liu Robert D Beauchamp Anna L Means The Journal of Pathology Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma Jing Yang James S Lewis Jinghuan Zi Thomas Andl Ethan Lee Claudia D Andl Qi Liu Robert D Beauchamp Anna L Means The Journal of Pathology AbstractSMAD4 is a tumor suppressor mutated or silenced in multiple cancers, including oral cavity squamous cell carcinoma (OSCC). Human clinical samples and cell lines, mouse models and organoid culture were used to investigate the role that SMAD4 plays in progression from benign disease to invasive OSCC. Human OSCC lost detectable SMAD4 protein within tumor epithelium in 24% of cases, and this loss correlated with worse progression‐free survival independent of other major clinical and pathological features. A mouse model engineered for KrasG12D expression in the adult oral epithelium induced benign papillomas, however the combination of KrasG12D with loss of epithelial Smad4 expression resulted in rapid development of invasive carcinoma with features of human OSCC. Examination of regulatory pathways in 3D organoid cultures of SMAD4+ and SMAD4− mouse tumors with Kras mutation found that either loss of SMAD4 or inhibition of TGFβ signaling upregulated the WNT pathway and altered the extracellular matrix. The gene signature of the mouse tumor organoids lacking SMAD4 was highly similar to the gene signature of human head and neck squamous cell carcinoma. In summary, this work has uncovered novel mechanisms by which SMAD4 acts as a tumor suppressor in OSCC. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6318 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| title | Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma |
| topic | The Journal of Pathology |
| url | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6318 |